Acknowledge the UWDC
Please acknowledge CSDE support on any of your publications, conference papers, and posters that used UWDC services. The text of that acknowledgment should read as follows:
“Support for data access and analyses for this research came from a Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant, P2C HD042828, to the Center for Studies in Demography and Ecology at the University of Washington.”
Research that CSDE supports through the UWDC
- Acolin A, Reina V. Housing cost burden and life satisfaction. Journal of Housing and the Built Environment. 2022.
- Acolin A, Colburn G, Walter RJ. How do single-family homeowners value residential and commercial density? It depends. Land Use Policy. 2022;113:105898.
- Barthold D, Marcum ZA, Chen S, et al. Difficulty with Taking Medications Is Associated with Future Diagnosis of Alzheimer’s Disease and Related Dementias. J Gen Intern Med. 2021;36(4):863-868.
- Clark SE, Marcum ZA, Radich JP, Bansal A. Predictors of tyrosine kinase inhibitor adherence trajectories in patients with newly diagnosed chronic myeloid leukemia. J Oncol Pharm Pract. 2021;27(8):1842-1852.
- Gold LS, Hansen RN, Patrick DL, et al. Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbations. Journal of Cystic Fibrosis. 2022.
- Gold LS, O’Reilly MK, Heagerty PJ, Jarvik JG. Complications and healthcare utilization in commercially-insured osteoporotic vertebral compression fracture patients: a comparison of kyphoplasty versus propensity-matched controls. The Spine Journal. 2021;21(8):1347-1354.
- Jiang S, Mathias PC, Hendrix N, et al. Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis. The Pharmacogenomics Journal. 2022.
- Jiao B, Basu A, Ramsey S, et al. Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review. Value in Health. 2022;25(2):276-287.
- Jiao B, Basu A, Roth J, et al. The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature. Pharmacoeconomics. 2021;39(11):1225-1241.
- Jiao B HJ, Devine B, Barton M, Bender M, Basu A. Mapping of generic PedsQL scores to utility values for individuals with sickle cell disease. Quality of Life Research. 2022.
- Lee JH, Shewale AR, Barthold D, Devine B. Geographic variation in the use of triptans and opioids for the acute treatment of migraine attacks. Headache: The Journal of Head and Face Pain. 2021;61(10):1499-1510.
- Samson PC, Holt SK, Hsi RS, Sorensen MD, Harper JD. The Association Between 24-Hour Urine and Stone Recurrence Among High Risk Kidney Stone Formers: A Population Level Assessment. Urology. 2020;144:71-76.
- Loftus CJ, Rajanahally S, Holt SK, Raheem OA, Ostrowski KA, Walsh TJ. Treatment Trends and Cost Associated With Peyronie’s Disease. Sex Med. 2020;8(4):673-678.
- Zamora-Kapoor A, Hebert LE, Montañez M, Buchwald D, Sinclair K. Risk Factors in Adolescence for the Development of Elevated Blood Pressure and Hypertension in American Indian and Alaskan Native Adults. J Immigr Minor Health. 2021;23(4):717-724.